Scripps 36th Annual New Treatments in Chronic Liver Disease 2022
This conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.
Welcome to the world of liver treatment and transplantation. In this conference, we will explore the latest medications and therapies that are revolutionizing the field of liver disease. From chronic viral hepatitis to hepatocellular carcinoma, this comprehensive program will update physicians on the most cutting-edge treatments available. Whether you are a hepatologist, gastroenterologist, or infectious disease specialist, this conference is designed to meet your educational needs.
One of the key highlights of this conference is the extensive review of the latest clinical trials and real-world data on oral drugs used to treat chronic viral hepatitis B and C. These medications have shown promising results in improving patient outcomes and reducing the burden of liver disease. We will also delve into the treatment of non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma, and complications of end-stage liver disease such as thrombocytopenia.
Educational Objectives:
Our educational objectives for this conference are designed to equip participants with the knowledge and skills necessary to effectively manage liver diseases:
- Assess AASLD guidelines on viral hepatitis, autoimmune hepatitis and reproductive health, and chronic liver disease.
- Review vascular disorders and coagulation management principles for patients with chronic liver disease.
- Summarize guidelines on NAFLD (AGA), DILI and hemochromatosis (ACG) and non-invasive markers of fibrosis (EASL).
- Evaluate drugs in development for PBC and PSC.
- Employ strategies for treating and managing ascites and hepatorenal syndrome.
- Describe advances in HCC therapy and management of acute-on-chronic liver disease.
Target Audience:
This conference is specifically designed for hepatologists, gastroenterologists, and infectious disease specialists. It is tailored to meet the unique educational needs of these healthcare professionals who play a crucial role in the management of liver diseases.
Topics:
The conference will cover a wide range of topics, presenting the latest advancements and best practices in the field:
- ACG Guidelines for DILI and Hemochromatosis – Kris Kowdley, MD
- Acute-on-Chronic Liver Disease – Timothy Morgan, MD
- Advanced Endoscopy in Liver Disease Patients – Matthew Skinner, MD
- Advances in HCC – Catherine Frenette, MD
- AGA Guidelines for NAFLD – Mazen Noureddin, MD
- Autoimmune Hepatitis – John Vierling, MD
- Debate- Use of Semaglutide for Obese Patients with NAFLD – Paul J. Pockros, MD, Michael Charlton, MD
- EASL Guidelines for Non-Invasive Testing – Michael Charlton, MD
- Reproductive Health and Chronic Liver Disease – Norah Terrault, MD
- Update on Management of Ascites and HRS – Florence Wong, MD
- Vascular Disorders and Anticoagulation – Patrick Northup, MD
- Viral Hepatitis B and C – Julio Gutierrez, MD
- When to Refer for Liver Transplantation – Adam Deising, MD
- WILLIAM S. HAUBRICH LECTURE- What’s New in PBC and PSC- – Kris Kowdley, MD
Why Attend?
Attending this conference is an opportunity to stay on top of the latest advancements in liver treatment and transplantation. With the field constantly evolving, it is crucial for physicians to stay updated with the most current strategies and treatments. By attending this conference, you will have access to leading experts in the field who will provide comprehensive insights and practical recommendations for managing liver diseases.
The conference offers a unique platform to network with colleagues from around the world, fostering collaborations and knowledge exchange. By engaging in discussions and panel sessions, you will have the chance to interact with experts and ask the questions that are most relevant to your own practice.
Ordering Information:
To order the book or video of this conference, simply visit our website and follow the easy ordering process. Our user-friendly platform ensures a seamless experience from start to finish.
By ordering the book or video, you can access the wealth of knowledge presented at the conference at your convenience. This valuable resource can serve as a reference guide for your daily practice, allowing you to stay updated with the latest treatments and strategies in liver disease management.
Don’t miss out on the opportunity to advance your knowledge and enhance your practice. Order the book or video of this conference today and take the next step in your professional development!